Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 2, 2004, Pages 400-405

  Nguyen, Paul L ^a   Whittington, Richard ^b   Koo, Sophia ^a   Schultz, Delray ^c   Cote, Kerri B ^a   Loffredo, Marian ^a   Tempany, Clare M ^a   Titelbaum, David S ^d   Schnall, Mitchell D ^b   Renshaw, Andrew A ^e   Tomaszewski, John E ^b   D'Amico, Anthony V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c MILLERSVILLE UNIVERSITY   (United States)

^d Shields Health Care ^*  (United States)

^e BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

Hormonal therapy; Magnetic resonance imaging; Prostate cancer; Radiation therapy; Seminal vesicle invasion

Indexed keywords

BIOPSY; HORMONES; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

EXTERNAL BEAM RADIOTHERAPY (EBRT); HORMONAL THERAPY; PROSTATE-SPECIFIC ANTIGEN (PSA);

ONCOLOGY;

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SEMINAL VESICLE DISEASE; SEMINAL VESICLE INVASION; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SEMINAL VESICLES; TREATMENT OUTCOME;

EID: 2442547692     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.035     Document Type: Article

References (23)

1. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 151:1994;172-173
2. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of PSA, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer A multi-institutional update. JAMA. 277:1997;1445-1451
3. D'Amico A.V., Whittington R.W., Malkowicz B.S., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:1998;969-974
4. D'Amico A.V., Whittington R.W., Malkowicz B.S., et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol. 166:2001;2185-2188
5. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. NEJM. 337:1997;295-300
6. Horiguchi A., Nakashima J., Horiguchi Y., et al. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. Prostate. 15:2003;56.:23-29
7. Ikonen S., Karkkainen P., Kivisaari L., et al. Endorectal magnetic resonance imaging of prostate cancer Comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual echo, steady-state sequences. Eur Radiol. 11:2001;236-241
8. Oh W.K., Kaplan I.D., Febbo P., et al. Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer. Am J Clin Oncol. 26:2003;312-316
9. Adusumilli S., Pretorius E.S. Magnetic resonance imaging of prostate cancer. Semin Urol Oncol. 20:2002;192-210
10. Jager G.J., Severens J.L., Thornbury J.R., et al. Prostate cancer staging Should MR imaging be used? A decision analytic approach. Radiology. 215:2000;445-451
11. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and post-operative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol. 14:1996;1770-1777
12. Sanchez-Chapado M., Angulo J.C., Ibarburen C., et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol. 32:1997;140-149
13. Huch Boni R.A., Boner J.A., Debatin J.F., et al. Optimization of prostate carcinoma staging Comparison of imaging and clinical methods. Clin Radiol. 50:1995;593-600
14. Presti J.C. Jr., Hricak H., Narayan P.A., et al. Local staging of prostatic carcinoma Comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol. 166:1996;103-108
15. th ed. Philadelphia (PA): Lippincott-Raven Publishers; 1992
16. Gleason D.F., Mellinge G.T. Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol. 111:1974;58-64
17. White S., Hricak H., Forstner R., et al. Prostate cancer Effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 193:1994;703-709
18. Yu K.K., Hricak H., Alagappan R., et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging Multivariate feature analysis. Radiology. 202:1997;697-702
19. Tempany C.M., Zhou X., Zerhouni E.A., et al. Staging of prostate cancer Results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology. 192:1994;47-54
20. Schnall M.D., Lenkinski R.E., Pollack H.M., et al. Prostate MR imaging with an endorectal surface coil. Radiology. 172:1989;570-574
21. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus Statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041
22. D'Amico A.V., Cote K., Loffredo M., et al. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol. 20:2002;4567-4573
23. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol. 164:2000;759-763